等待開盤 03-26 09:30:00 美东时间
-0.790
-4.09%
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
今天 11:41
Morgan Stanley analyst Connor Lynagh maintains Sportradar Gr (NASDAQ:SRAD) with a Equal-Weight and lowers the price target from $26 to $24.
今天 01:45
Polymarket to start charging fees on March 30, expanding beyond crypto and sports contracts. Probability-based model with fees up to 1.80%.
03-24 23:30
MLB and Polymarket signed a multi-year deal worth up to $300 million. The league also partnered with the CFTC to protect prediction markets.
03-19 22:45
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Sportradar shares are trading higher. The company reported its Q4 financial res...
03-05 00:10
BTIG analyst Clark Lampen maintains Sportradar Gr (NASDAQ:SRAD) with a Buy and lowers the price target from $32 to $24.
03-04 18:02
Sportradar Gr (NASDAQ:SRAD) sees FY2026 sales of $1.813 billion-$1.842 billion vs $1.860 billion analyst estimate.
03-03 20:04
The earnings results for Sportradar Gr (NASDAQ:SRAD) for Q4 were made public on...
03-03 20:04